Novel preclinical models and biomarkers for prostate cancer

被引：0
|
作者：
Korzeniewski, N. [1 ]
Tapia-Laliena, M. [1 ]
Tolstov, Y. [1 ]
Pahernik, S. [2 ]
Hadaschik, B. [2 ]
Hohenfellner, M. [2 ]
Duensing, S. [1 ,2 ]
机构：
[1] Univ Klinikum Heidelberg, Sekt Mol Uroonkol, Urol Univ Klin, D-69120 Heidelberg, Germany
[2] Univ Klinikum Heidelberg, Urol Univ Klin, D-69120 Heidelberg, Germany
来源：
UROLOGE | 2013年 / 52卷 / 09期
关键词：
Therapy; oncological; Genetically engineered mouse model; Xenograft model; Androgen ablation; Metastasization; osseous; REARRANGEMENT; MECHANISMS; FUSION;
D O I：
10.1007/s00120-013-3310-6
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The ultimate goal of a personalized approach to prostate cancer patient management relies on two prerequisites: the development of preclinical but clinically relevant model systems and robust prognostic and predictive biomarkers. The past several years have shown significant progress towards these two prerequisites which will be highlighted in this review using some notable examples.
引用
收藏
页码：1256 / 1260
页数：5
相关论文
共 50 条
  • [1] Preclinical models of prostate cancer
    Royai, R
    Lange, PH
    Vessella, R
    [J]. SEMINARS IN ONCOLOGY, 1996, 23 (06) : 35 - 40
  • [2] Preclinical models of prostate cancer
    Fizazi, K
    Navone, NM
    [J]. BULLETIN DU CANCER, 2005, 92 (02) : 129 - 141
  • [3] Novel preclinical models and biomarkers for prostate cancer [Neue präklinische Modelle und Biomarker beim Prostatakarzinom]
    Korzeniewski N.
    Tapia-Laliena M.
    Tolstov Y.
    Pahernik S.
    Hadaschik B.
    Hohenfellner M.
    Duensing S.
    [J]. Der Urologe, 2013, 52 (9): : 1256 - 1260
  • [4] Preclinical Models of Neuroendocrine Prostate Cancer
    Cacciatore, Alessia
    Albino, Domenico
    Catapano, Carlo V.
    Carbone, Giuseppina M.
    [J]. CURRENT PROTOCOLS, 2023, 3 (05):
  • [5] PROSTATE CANCER Novel xenografts in mice-a new wave of preclinical models
    Risbridger, Gail P.
    [J]. NATURE REVIEWS UROLOGY, 2015, 12 (10) : 540 - 541
  • [6] Novel preclinical models of aggressive variants of castration-resistant prostate cancer
    Bigot, Ludovic
    Sabio, Jonathan
    Ibrahim, Tony
    Menssouri, Naoual
    Poiraudeau, Loic
    Helissey, Carole
    Scoazec, Jean-Yves
    Merabet, Zahira
    De Baere, Thierry
    Deschamps, Frederic
    Ngocamus, Maud
    Nicotra, Claudio
    Rouleau, Etienne
    Lacroix, Ludovic
    Deas, Olivier
    Friboulet, Luc
    Vassal, Gilles
    Solary, Eric
    Soria, Jean-Charles
    Fizazi, Karim
    Andre, Fabrice
    Massard, Christophe
    Besse, Benjamin
    Loriot, Yohann
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [7] Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer
    Devlies, Wout
    Handle, Florian
    Devos, Gaetan
    Joniau, Steven
    Claessens, Frank
    [J]. CANCERS, 2021, 13 (04) : 1 - 17
  • [8] Novel diagnostic biomarkers for prostate cancer
    Madu, Chikezie O.
    Lu, Yi
    [J]. JOURNAL OF CANCER, 2010, 1 : 150 - 177
  • [9] Novel biomarkers for the detection of prostate cancer
    Jakobsen, Niels Asger
    Hamdy, Freddie Charles
    Bryant, Richard John
    [J]. JOURNAL OF CLINICAL UROLOGY, 2016, 9 (02) : 3 - 10
  • [10] NOVEL BIOMARKERS FOR AGGRESSIVE PROSTATE CANCER
    Christudass, Christhunesa
    Lelin, Andrew
    Partin, Alan
    Luo, Jun
    Veltri, Robert
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E921 - E921
12345